UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
International journal of alzheimer's disease, ISSN 2090-0252, 06/2011, Volume 2011, pp. 729478 - 10
Journal Article
Frontiers in neuroscience, ISSN 1662-4548, 05/2019, Volume 13, pp. 509 - 509
Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Advertising executives | Algorithms | Image processing | Neural networks | Machine learning | Diagnostic imaging | Data mining | Artificial intelligence | Alzheimer's disease | Cable television broadcasting industry | Brain | Medical imaging | Segmentation | Neurodegenerative diseases | Cognitive ability | Metabolism | Deep learning | Learning algorithms | Teaching methods | Magnetic resonance imaging | Classification | Biomarkers | Diagnosis | Positron emission tomography | Hippocampus | Dementia | deep learning | multi-modality | CNN | hippocampal | Alzheimer’s disease | image classification
Journal Article
PloS one, ISSN 1932-6203, 05/2019, Volume 14, Issue 5, pp. e0216413 - e0216413
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Neuroimaging | Signs and symptoms | Medical imaging | Activities of daily living | Cognitive ability | Systematic review | Mental depression | Risk analysis | Apolipoproteins | Risk factors | Consortia | Proteins | Neurology | Algorithms | Cognition & reasoning | Etiology | Dementia disorders | Biomarkers | Bioindicators | Dementia | Index Medicus
Journal Article
EMBO molecular medicine, ISSN 1757-4676, 09/2020, Volume 12, Issue 9, pp. e12308 - n/a
tau | protective | TREM2 | microglia | beta‐amyloid accumulation | beta-amyloid accumulation | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Pathogens | Immune response | Neurodegenerative diseases | Cerebrospinal fluid | Microglia | Proteins | Pathology | Tau protein | Biomarkers | Amyloidosis | Alzheimers disease | Positron emission tomography | Alzheimer's disease | Age | Plaques | Dementia | Index Medicus | Neuroscience | Biomarkers & Diagnostic Imaging
Journal Article
Current Alzheimer research, ISSN 1567-2050, 01/2015, Volume 12, Issue 3, pp. 218 - 227
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Genetic Predisposition to Disease | Genome-Wide Association Study | Apolipoprotein E4 - genetics | Follow-Up Studies | Humans | Databases, Factual - statistics & numerical data | Genotype | Logistic Models | Male | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Alzheimer Disease - pathology | Magnetic Resonance Imaging | Analysis of Variance | Brain - pathology | Polymorphism, Single Nucleotide - genetics | Female | Aged | Alzheimer Disease - genetics
Journal Article
6.
Full Text
Associations between APOE genotype and cerebral small-vessel disease: A longitudinal study
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 27, pp. 44477 - 44489
White matter hyperintensities (WMH) | Apolipoprotein E (APOE) | Cerebral small-vascular disease (CSVD) | Cognition | Dilated perivascular space (dPVS) | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Neuroimaging | Humans | Middle Aged | Cognitive Dysfunction | tau Proteins - metabolism | Male | Cerebrovascular Disorders - metabolism | Positron-Emission Tomography | Amyloid beta-Peptides - metabolism | Aged, 80 and over | Female | Genetic Predisposition to Disease | Genetic Association Studies | Comorbidity | Risk Factors | Genotype | Cerebrovascular Disorders - etiology | Disease Progression | Neuropsychological Tests | Magnetic Resonance Imaging | Cerebrovascular Disorders - diagnosis | Apolipoproteins E - genetics | Alleles | Biomarkers | Aged | Cerebrovascular Disorders - genetics | Longitudinal Studies | Index Medicus
Journal Article
7.
Full Text
Hierarchical anatomical brain networks for MCI prediction: Revisiting volumetric measures
PloS one, ISSN 1932-6203, 2011, Volume 6, Issue 7, pp. e21935 - e21935
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Magnetic Resonance Imaging | Humans | Brain - pathology | Female | Male | Aged | Cognitive Dysfunction - diagnosis | Cognitive Dysfunction - pathology | Models, Neurological | Nerve Net - pathology | Medicine, Experimental | Medical research | Advertising executives | Alzheimer's disease | Medical imaging equipment | Neuroimaging | Brain | Correlation | Nuclear magnetic resonance--NMR | Image processing | Noise | Cognitive ability | Embedding | Cerebrospinal fluid | Substantia grisea | Noise sensitivity | Registration | Older people | Spots | Classification | Medical imaging | Neurodegenerative diseases | Magnetic resonance | Data processing | Substantia alba | Studies | Pathology | Neurology | Magnetic resonance imaging | Correlation analysis | Feature extraction | Alzheimers disease | Psychiatry | Index Medicus | Nuclear magnetic resonance | NMR
Journal Article
Alzheimer's research & therapy, ISSN 1758-9193, 10/2020, Volume 12, Issue 1, pp. 1 - 133
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Glucose metabolism | Advertising executives | PET imaging | Alzheimer's disease | Immunoassay | Medical imaging | Memory | Cognitive ability | Asymptomatic | Regions | Metabolism | Pathology | Older people | Biomarkers | Standard deviation | Alzheimers disease | Dementia | Index Medicus | FDG-PET | Amyloid-PET | Hypermetabolism | Mild cognitive impairment | Tau-PET | Hyperactivation
Journal Article
Alzheimer's research & therapy, ISSN 1758-9193, 04/2017, Volume 9, Issue 1, pp. 32 - 32
ADNI | MCI | CSF markers | Amyloid PET | Alzheimer's disease | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Risk Assessment - methods | Prevalence | Prognosis | Cognition Disorders - diagnostic imaging | Humans | Middle Aged | Male | Sensitivity and Specificity | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Alzheimer Disease - epidemiology | Female | Databases, Factual | Cognition Disorders - cerebrospinal fluid | Diagnosis, Differential | France - epidemiology | Reproducibility of Results | Peptide Fragments - cerebrospinal fluid | Radiopharmaceuticals - pharmacokinetics | Comorbidity | tau Proteins - cerebrospinal fluid | Biomarkers - blood | Positron-Emission Tomography - methods | Alzheimer Disease - cerebrospinal fluid | Positron-Emission Tomography - statistics & numerical data | Aged | Alzheimer Disease - diagnostic imaging | Cognition Disorders - epidemiology | Studies | Neurology | Researchers | Medical imaging | Activities of daily living | Cognition & reasoning | Older people | Memory | Cognitive ability | Biomarkers | Dementia | Index Medicus | Life Sciences | Alzheimer’s disease
Journal Article
Frontiers in aging neuroscience, ISSN 1663-4365, 11/2020, Volume 12, pp. 572732 - 572732
Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Geriatrics & Gerontology | Science & Technology | Medical imaging | Disease | Neurodegenerative diseases | Memory | Brain mapping | Cognitive ability | Synchronization | Risk factors | Functional magnetic resonance imaging | Aging | Auditory discrimination learning | Alzheimers disease | Alzheimer's disease | Smoking | Dementia | Structure-function relationships | Alzheimer’s disease | amnestic mild cognitive impairment | regional homogeneity | resting-state functional magnetic resonance | smoking
Journal Article